Reflexion Health valued at $35M with $18M Series B
June 27, 2016
Reflexion Health’s core product, Vera, is an FDA-cleared interactive software that uses sensors to measure motion and remotely monitor the effectiveness of prescribed physical therapy. This round follows a $7.5 million Series A financing the company secured in 2014 at a $22 million valuation. Previous investors include West Health Investment Fund.